US Patent Issued to Tolremo Therapeutics on Nov. 25 for "Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer" (Dutch, Swiss Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,624, issued on Nov. 25, was assigned to Tolremo Therapeutics AG (Zurich).

"Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer" was invented by Stefanie Fluckiger-Mangual (Muttenz, Switzerland), Dorothea Gruber (Muttenz, Switzerland), Rutger Folmer (Wijchen, Netherlands), Koen F. W. Hekking (Nijmegen, Netherlands), Johan J. N. Veerman (Volendam, Netherlands), Martijn Eerland (Lent, Netherlands) and Charles-Henry Fabritius (Muttenz, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound of formula (I), optionally in the form of a pharmaceuticall...